Philips Ultrasound Imaging Systems Recalled Following Four Deaths and Eight Serious Injuries

The U.S. Food and Drug Administration (FDA) has announced a recall of certain Philips Lumify line of diagnostic ultrasound imaging systems. A software issue may prevent the associated Android or iOS app from recognizing a previously registered account, potentially halting scanning functionality. This issue, along with unstable USB connections, has been linked to four deaths and eight serious injuries, particularly in pre-hospital settings with limited connectivity.